These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22900509)

  • 1. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.
    Lynch JC; Welling L; Escosteguy C; Pereira AG; Andrade R; Pereira C
    Br J Neurosurg; 2013 Feb; 27(1):80-3. PubMed ID: 22900509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
    Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
    Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
    Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
    J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.
    Fujii O; Soejima T; Kuwatsuka Y; Harada A; Ota Y; Tsujino K; Sasaki M; Kudo H; Nishihara M; Taomoto K
    Jpn J Clin Oncol; 2010 Aug; 40(8):726-31. PubMed ID: 20410057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
    Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.
    Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S
    Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in adult cerebellar glioblastoma.
    Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
    J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical prognostic factors of adult supratentorial glioblastoma].
    Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
    Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme.
    Muacevic A; Kreth FW
    J Neurol; 2003 May; 250(5):561-8. PubMed ID: 12736735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors influencing clinical outcomes of glioblastoma multiforme.
    Li SW; Qiu XG; Chen BS; Zhang W; Ren H; Wang ZC; Jiang T
    Chin Med J (Engl); 2009 Jun; 122(11):1245-9. PubMed ID: 19567131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
    Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
    J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme.
    Helseth R; Helseth E; Johannesen TB; Langberg CW; Lote K; Rønning P; Scheie D; Vik A; Meling TR
    Acta Neurol Scand; 2010 Sep; 122(3):159-67. PubMed ID: 20298491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.